Oct 21, 2026, 11:17 AM
Board meeting scheduled to consider Q3 2026 financial results
Board MeetingGlaxoSmithKline Pakistan Limited announced that its Board of Directors will meet on October 29, 2026, at 12:00 noon in Karachi and via video link to consider financial results for the quarter ended September 30, 2026. A closed period applies from October 22 through October 29, 2026, inclusive.
Key Findings
- The board meeting is scheduled for October 29, 2026, at 12:00 noon.
- The agenda is consideration of financial results for the quarter ended September 30, 2026.
- The closed period runs from October 22 to October 29, 2026, inclusive.
Meeting Details
Meeting time
2026-10-29 12:00
Location
Karachi and via video link
Agenda
Financial results
Financial Period
Quarter ended September 30, 2026
⚡
Highlights summarize the key points from the company's official PSX filing. View the original filing for the complete details before making financial decisions.